Our Pricing

Viagra in Women: Understanding Effects, Safety and UK Alternatives

The use of viagra in women has generated considerable clinical interest, yet sildenafil citrate remains unlicensed for female sexual dysfunction in the UK. While Viagra is well-established for treating erectile dysfunction in men, research into its effects on women has produced mixed results, with most studies showing limited benefit for conditions like female sexual arousal disorder [1]. Understanding the current evidence, safety profile, and licensed alternatives is essential for women exploring treatment options for sexual health concerns.

How Viagra in Women Affects Physiology

Viagra in women works through the same mechanism as in men—inhibiting phosphodiesterase type 5 (PDE5) to increase blood flow to genital tissues [1]. The theory suggests that enhanced blood flow could improve vaginal lubrication and clitoral sensitivity, potentially addressing symptoms of female sexual arousal disorder. However, female sexual function involves complex psychological, hormonal, and vascular components that extend beyond simple blood flow enhancement.

Clinical trials examining viagra in women have shown inconsistent results. A 2008 systematic review found that while sildenafil increased genital blood flow in laboratory settings, this physiological change did not consistently translate to improved sexual satisfaction or arousal in real-world scenarios [2]. The disconnect between physical response and subjective arousal highlights that female sexual dysfunction often requires a more comprehensive treatment approach than medication alone.

Safety Considerations for Viagra in Women

The safety profile of viagra in women has been evaluated in multiple clinical trials, with most studies reporting similar side effects to those seen in men [2]. Common adverse effects include headache, facial flushing, nasal congestion, and visual disturbances. These effects result from sildenafil's action on blood vessels throughout the body, not just in genital tissue.

Critically, viagra in women is contraindicated when taking nitrate medications for heart conditions, as the combination can cause dangerous blood pressure drops. Women with cardiovascular disease, retinal disorders, or severe liver impairment require careful medical assessment before considering sildenafil use [3]. The MHRA has not licensed sildenafil for female sexual dysfunction, meaning any use would be off-label and subject to prescriber discretion.

Hormonal Interactions and Pregnancy

Viagra in women may interact with hormonal contraceptives and hormone replacement therapy, though clinical data remains limited. More importantly, sildenafil is not recommended during pregnancy or breastfeeding due to insufficient safety data [3]. Women of childbearing age considering sildenafil should discuss effective contraception with their prescriber and immediately discontinue use if pregnancy occurs.

Clinical Evidence for Viagra in Women

Research into viagra in women peaked in the early 2000s, with several pharmaceutical companies investigating sildenafil for female sexual arousal disorder. A landmark 2003 study published in JAMA examined 781 premenopausal women with sexual dysfunction and found no significant improvement in arousal or satisfaction compared to placebo [1]. This disappointing result led to the discontinuation of most commercial development programmes.

Subsequent trials focused on specific subgroups, including postmenopausal women and those with sexual dysfunction secondary to antidepressant use. A 2008 study showed modest improvements in arousal among women taking selective serotonin reuptake inhibitors (SSRIs), suggesting viagra in women might benefit certain populations [2]. However, the overall evidence base remains insufficient for regulatory approval in the UK.

Psychological Components of Female Sexual Function

The limited efficacy of viagra in women reflects the multifaceted nature of female sexual response. Unlike male erectile dysfunction, which often has a primarily vascular component, female sexual dysfunction typically involves psychological factors, relationship dynamics, hormonal influences, and cultural contexts [4]. This complexity explains why a medication targeting blood flow alone shows limited benefit in clinical trials.

Licensed Alternatives to Viagra in Women UK

While viagra in women remains unlicensed in the UK, several approved treatments address female sexual dysfunction through different mechanisms. Flibanserin (Addyi) targets neurotransmitters in the brain and is licensed in the United States for hypoactive sexual desire disorder in premenopausal women, though it is not currently available through the NHS [4]. Topical oestrogen preparations effectively treat vaginal dryness and atrophy in postmenopausal women, addressing a common cause of sexual discomfort.

Non-pharmacological approaches often form the first-line treatment for female sexual dysfunction in UK clinical practice. Psychological therapies, particularly cognitive behavioural therapy and sex therapy, demonstrate strong evidence for improving sexual satisfaction and addressing underlying relationship or anxiety issues [4]. Pelvic floor physiotherapy can benefit women with vaginismus or pelvic pain affecting sexual function. At Cured Pharmacy, our clinical team can assess individual circumstances and recommend appropriate licensed treatments, with prices starting from £9.19 subject to prescriber approval.

Viagra in Women: Off-Label Prescribing in the UK

Some UK prescribers may consider off-label use of viagra in women after thorough assessment and discussion of the limited evidence base. Off-label prescribing is legal and sometimes clinically appropriate when licensed alternatives have failed or are unsuitable [3]. However, prescribers must ensure informed consent, documenting that the patient understands sildenafil is not licensed for female sexual dysfunction and that evidence of benefit is limited.

The decision to prescribe viagra in women off-label requires careful consideration of potential benefits versus risks, particularly in women with cardiovascular risk factors or taking interacting medications. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all prescribing decisions at Cured Pharmacy follow GMC and GPhC guidance on off-label use, prioritising patient safety and informed choice.

Dosing Considerations

When viagra in women is prescribed off-label, dosing typically mirrors male protocols, starting at 50mg taken approximately one hour before sexual activity [1]. Some prescribers may initiate treatment at 25mg to assess tolerance before increasing the dose. Unlike daily tadalafil regimens sometimes used in men, sildenafil for women is generally prescribed on an as-needed basis due to the lack of data supporting continuous use.

Accessing Treatment for Viagra in Women Through Cured Pharmacy

Women considering viagra in women or alternative treatments for sexual dysfunction can complete a confidential online consultation at Cured Pharmacy. Our UK-registered clinical team assesses medical history, current medications, and specific symptoms to determine the most appropriate treatment approach. The consultation takes under three minutes and is reviewed by qualified prescribers who can discuss both licensed and off-label options where clinically suitable.

All medications dispensed by Cured Pharmacy are genuine UK-licensed products supplied in 100% discreet packaging. We guarantee the lowest prices in the UK, with transparent upfront pricing shown before consultation. For women seeking alternatives to viagra in women, our clinical team can recommend licensed treatments for related conditions such as vaginal atrophy or provide referrals for psychological therapies when appropriate. Treatment options start from £9.19, with 20% off your first order using code Ednew, subject to prescriber approval and clinical suitability.

Scientific References

1. Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002). Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. Journal of Women's Health & Gender-Based Medicine, 11(4), 367-377.
2. Nurnberg, H. G., Hensley, P. L., Heiman, J. R., Croft, H. A., Debattista, C., & Paine, S. (2008). Sildenafil treatment of women with antidepressant-associated sexual dysfunction. JAMA, 300(4), 395-404.
3. Medicines and Healthcare products Regulatory Agency. (2021). Sildenafil: Summary of Product Characteristics. UK Government.
4. National Institute for Health and Care Excellence. (2023). Sexual dysfunction in women: Assessment and management. NICE Clinical Knowledge Summary.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.